Significados de identical sibling en inglés

No effect was seen in patients grafted from HLA- identical sibling donors.

However, fewer than 30% of individuals will have an HLA- identical sibling.

Allogeneic bone marrow transplantation remains largely limited to young patients with an HLA- identical sibling donor.

Unrelated donor transplantation, however, is still associated with higher complication rates than in HLA- identical sibling donor transplants.

Despite of this ALG is the treatment of choice for patients without an HLA identical sibling donor.

The value of administering consolidation chemotherapy before human leukocyte antigen (HLA)- identical sibling transplantation is not established.

Compared with 28 case-matched controls transplanted with HLA identical sibling donors, MUD patients received a more intensive conditioning.

The evolution is always fatal unless, the patient receives a bone marrow transplant from an HLA identical sibling.

Patients were conditioned with total body radiation and cyclophosphamide followed by bone marrow infusion from an HLA- identical sibling.

Conclusions: Modest increases in leukemia-free survival rates occurred after human lymphocyte antigen- identical sibling bone marrow transplants in the 1980s.

A 21-year-old male diagnosed with acute myeloid leukemia received an allogeneic HSCT from human leukocyte antigen- identical sibling donor.

In conclusion, alemtuzumab dose reduction to 30 mg is safe in the context of reduced intensity conditioning and HLA- identical sibling transplantation.

Fourteen patients received marrow from an identical sibling donor, one from the phenoidentical father and three from a matched unrelated donor.

We conclude that G-BM is an excellent stem-cell source that may be preferable to G-PBSC or SS-BM in patients receiving HLA- identical sibling hematopoietic stem-cell transplantation.

We analysed data from 114 recipients of HLA- identical sibling transplants who relapsed and received a second transplant between 1978 and 1989.

Since 1993, 262 patients with hematologic malignancies received a T cell-depleted myeloablative HSCT from an HLA- identical sibling at a single center.